Latest filing published 17 Jul 2026 for COLLEGIUM PHARMACEUTICAL, INC, €435k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Fallon John A. discloses dealings in Collegium Pharmaceutical, Inc to SEC (Form 4). In total, 2 filings cover trades dated from 15 July 2026 to 17 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 17 July 2026 with a transaction (€435k) in Collegium Pharmaceutical, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations